In order to assess the mutations in GK affecting the catalysis process, in silico mutagenic studies will help in revealing the effect of structural and functional variations with respect to mutations in the enzyme such that the same can be exploited to explain the MODY2 condition in type 2 diabetic patients. This evidence concerns the gene GK and type 2 diabetes mellitus.